|
|
|
Milestone Pharmaceuticals inc (NASDAQ: MIST) |
|
Milestone Pharmaceuticals inc
MIST's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Milestone Pharmaceuticals Inc 's sales fell
in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.88 %
Milestone Pharmaceuticals Inc net loss decreased from $-14 millions, to $-12 millions in IV. Quarter 2024,
• More on MIST's Growth
|
|
Milestone Pharmaceuticals Inc
realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 11.64 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.33.
• More on MIST's Valuation
|
|
|
|
|
Milestone Pharmaceuticals Inc
realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 11.64 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.33.
Milestone Pharmaceuticals Inc Price to Book Ratio is at 10.23 lower than Industry Avg. of 91.07. and higher than S&P 500 Avg. of 0.01
• More on MIST's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
